The effectiveness of instrument-assisted soft tissue mobilization on pain and function in patients with musculoskeletal disorders: a systematic review and meta-analysis DOI Creative Commons

Sien Tang,

Li Sheng,

Xiating Wei

и другие.

BMC Musculoskeletal Disorders, Год журнала: 2025, Номер 26(1)

Опубликована: Март 14, 2025

Instrument-assisted soft tissue mobilization (IASTM) is popular in the treatment of musculoskeletal disorders. However, current literature has produced varying results. The purpose this study was to collect most recent studies evaluate effectiveness IASTM on pain and function patients with researchers searched PubMed, Embase, Web Science, Cochrane Library databases from inception February 25, 2025, identify randomized controlled trials comparing groups receiving combined other treatments those among participants outcomes were intensity, pressure threshold function. Cochran Q I² indices used estimate heterogeneity. data analyzed as standardized mean difference (SMD). Risk Bias tool assess risk bias. Grading Recommendations Assessment, Development, Evaluation system rate quality evidence. Trial sequential analysis sensitivity analyses also performed. Eleven (involving 427 participants) included quantitative analysis. Six had a high bias; three, unclear; two, low. There moderate-certainty evidence indicating that effective reducing patient-reported (n = 11) 427, SMD 0.60, 95% CI: 0.41 0.80, p < 0.01), there low-certainty improving 8) 333, 0.40, 0.03 0.77, 0.05). Only one point extracted for threshold, meta-analysis not revealed cumulative z score crossed monitoring boundary superiority nonspecific chronic neck cervicogenic headache at 4-week IASTM. can reduce (with moderate certainty) improve low Future clinical do need explore short-term effects headache. PROSPERO registration ID CRD42024534643 (April 10, 2024).

Язык: Английский

The effectiveness of instrument-assisted soft tissue mobilization on pain and function in patients with musculoskeletal disorders: a systematic review and meta-analysis DOI Creative Commons

Sien Tang,

Li Sheng,

Xiating Wei

и другие.

BMC Musculoskeletal Disorders, Год журнала: 2025, Номер 26(1)

Опубликована: Март 14, 2025

Instrument-assisted soft tissue mobilization (IASTM) is popular in the treatment of musculoskeletal disorders. However, current literature has produced varying results. The purpose this study was to collect most recent studies evaluate effectiveness IASTM on pain and function patients with researchers searched PubMed, Embase, Web Science, Cochrane Library databases from inception February 25, 2025, identify randomized controlled trials comparing groups receiving combined other treatments those among participants outcomes were intensity, pressure threshold function. Cochran Q I² indices used estimate heterogeneity. data analyzed as standardized mean difference (SMD). Risk Bias tool assess risk bias. Grading Recommendations Assessment, Development, Evaluation system rate quality evidence. Trial sequential analysis sensitivity analyses also performed. Eleven (involving 427 participants) included quantitative analysis. Six had a high bias; three, unclear; two, low. There moderate-certainty evidence indicating that effective reducing patient-reported (n = 11) 427, SMD 0.60, 95% CI: 0.41 0.80, p < 0.01), there low-certainty improving 8) 333, 0.40, 0.03 0.77, 0.05). Only one point extracted for threshold, meta-analysis not revealed cumulative z score crossed monitoring boundary superiority nonspecific chronic neck cervicogenic headache at 4-week IASTM. can reduce (with moderate certainty) improve low Future clinical do need explore short-term effects headache. PROSPERO registration ID CRD42024534643 (April 10, 2024).

Язык: Английский

Процитировано

0